Mary E. Herman

3.4k total citations · 1 hit paper
20 papers, 2.4k citations indexed

About

Mary E. Herman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mary E. Herman has authored 20 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Mary E. Herman's work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (7 papers) and Diabetes Management and Research (7 papers). Mary E. Herman is often cited by papers focused on Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (7 papers) and Diabetes Management and Research (7 papers). Mary E. Herman collaborates with scholars based in United States, Italy and Canada. Mary E. Herman's co-authors include Martin L. Freeman, Douglas B. Nelson, Gregory Haber, Joseph P. Moore, Michael J. Shaw, Michael E. Ryan, Alfred M. Pheley, M. Brian Fennerty, Jeffrey D. Lande and S Sherman and has published in prestigious journals such as New England Journal of Medicine, Trends in Endocrinology and Metabolism and Gastrointestinal Endoscopy.

In The Last Decade

Mary E. Herman

20 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complications of Endoscopic Biliary Sphincterotomy

1996 1.8k citations Martin L. Freeman, Douglas B. Nelson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Herman United States	12	1.8k	1.8k	1.2k	239	207	20	2.4k
Djuna L. Cahen Netherlands	26	2.1k 1.1×	706 0.4×	1.8k 1.5×	257 1.1×	75 0.4×	84	2.9k
Hajime Imai Japan	25	1.2k 0.6×	818 0.5×	1.1k 0.9×	289 1.2×	20 0.1×	77	2.0k
Eberhard Mack United States	23	1.1k 0.6×	436 0.2×	461 0.4×	78 0.3×	237 1.1×	48	1.8k
Koki Otsuka Japan	19	728 0.4×	325 0.2×	485 0.4×	163 0.7×	50 0.2×	101	1.3k
Keisuke Koeda Japan	24	1.1k 0.6×	1.5k 0.8×	470 0.4×	281 1.2×	22 0.1×	86	2.3k
Arnaud Lemmers Belgium	22	874 0.5×	707 0.4×	425 0.3×	224 0.9×	86 0.4×	76	2.3k
Lucio Gullo Italy	25	1.3k 0.7×	178 0.1×	1.3k 1.1×	239 1.0×	96 0.5×	58	2.1k
F. A. Wenger Germany	20	1.0k 0.6×	227 0.1×	432 0.4×	152 0.6×	51 0.2×	60	1.6k
G Fourtanier France	23	1.5k 0.8×	703 0.4×	1.2k 1.0×	85 0.4×	35 0.2×	89	2.2k
Keita Terui Japan	21	872 0.5×	442 0.2×	289 0.2×	303 1.3×	39 0.2×	111	1.7k

Countries citing papers authored by Mary E. Herman

Since Specialization

Citations

This map shows the geographic impact of Mary E. Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Herman more than expected).

Fields of papers citing papers by Mary E. Herman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Herman. The network helps show where Mary E. Herman may publish in the future.

Co-authorship network of co-authors of Mary E. Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Herman. A scholar is included among the top collaborators of Mary E. Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Herman. Mary E. Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwartz, Stanley S., Elizabeth M. Rhea, William A. Banks, & Mary E. Herman. (2025). Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's disease. PubMed. 3(2). 145–164. 1 indexed citations

Schwartz, Stanley S., Barbara E. Corkey, James R. Gavin, Ralph A. DeFronzo, & Mary E. Herman. (2024). Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines. BMC Medicine. 22(1). 356–356. 2 indexed citations

Schwartz, Stanley S. & Mary E. Herman. (2024). Gluco-regulation & type 2 diabetes: entrenched misconceptions updated to new governing principles for gold standard management. Frontiers in Endocrinology. 15. 1394805–1394805. 1 indexed citations

Schwartz, Stanley S., et al.. (2024). The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes. BMC Medicine. 22(1). 582–582. 11 indexed citations

Miller, Eden, Richard Aguilar, Mary E. Herman, & Stanley S. Schwartz. (2019). Type 2 diabetes: Evolving concepts and treatment. Cleveland Clinic Journal of Medicine. 86(7). 494–504. 6 indexed citations

Schwartz, Stanley S., Struan F.A. Grant, & Mary E. Herman. (2019). Intersections and Clinical Translations of Diabetes Mellitus with Cancer Promotion, Progression and Prognosis. Postgraduate Medicine. 131(8). 597–606. 11 indexed citations

Scheiner, Gary, Stanley S. Schwartz, & Mary E. Herman. (2018). Managing Diabetes by Maintaining Healthier Beta Cells: A Fresh Perspective for Diabetes Educators. 6(4). 12–18. 3 indexed citations

Schwartz, Stanley S., Solomon Epstein, Barbara E. Corkey, et al.. (2017). A Unified Pathophysiological Construct of Diabetes and its Complications. Trends in Endocrinology and Metabolism. 28(9). 645–655. 81 indexed citations

Herman, Mary E., James H. O’Keefe, David S.H. Bell, & Stanley S. Schwartz. (2017). Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes. Progress in Cardiovascular Diseases. 60(3). 422–434. 85 indexed citations

10.

Schwartz, Stanley S., Paul S. Jellinger, & Mary E. Herman. (2016). Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile. Postgraduate Medicine. 128(6). 609–619. 18 indexed citations

11.

Sadhu, Archana, Stanley S. Schwartz, & Mary E. Herman. (2015). The Rationale for use of Incretins in the Management of new Onset Diabetes After Transplantation (NODAT). Endocrine Practice. 21(7). 814–822. 15 indexed citations

12.

Schwartz, Stanley S. & Mary E. Herman. (2015). Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies. Postgraduate Medicine. 127(5). 480–493. 10 indexed citations

13.

Clouse, Jon, et al.. (2002). Health economic considerations in the management of type 2 diabetes.. PubMed. 15(1). 66–71. 5 indexed citations

14.

Nelson, Douglas B., Martin L. Freeman, Oliver W. Cass, et al.. (2000). A randomized, controlled trial of transcutaneous carbon dioxide monitoring during ERCP. Gastrointestinal Endoscopy. 51(3). 288–295. 53 indexed citations

15.

Freeman, Martin L., Douglas B. Nelson, Stuart Sherman, et al.. (1999). Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. Gastrointestinal Endoscopy. 49(5). 580–586. 64 indexed citations

16.

Katzenellenbogen, Benita S., Monica M. Montano, Kirk Ekena, Mary E. Herman, & Eileen M. McInerney. (1997). Antiestrogens: Mechanisms of action and resistance in breast cancer. Breast Cancer Research and Treatment. 44(1). 23–38. 156 indexed citations

17.

Freeman, Martin L., Douglas B. Nelson, S Sherman, et al.. (1996). Complications of Endoscopic Biliary Sphincterotomy. New England Journal of Medicine. 335(13). 909–919. 1808 indexed citations breakdown →

18.

Herman, Mary E. & Benita S. Katzenellenbogen. (1996). Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. The Journal of Steroid Biochemistry and Molecular Biology. 59(2). 121–134. 53 indexed citations

19.

Freeman, Martin L., Shawn Mallery, S. Sherman, et al.. (1996). Pancreatitis complicating endoscopic biliary sphincterotomy (ES): A prospective multivariate analysis of risk factors including pancreatic sphincter hypertension (PSH). Gastrointestinal Endoscopy. 43(4). 381–381. 2 indexed citations

20.

Herman, Mary E. & Benita S. Katzenellenbogen. (1994). Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.. PubMed. 54(22). 5867–74. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact